Is Alkermes Plc halal to invest in?

As of July 2026, Alkermes Plc ALKS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Alkermes Plc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alkermes Plc using these criteria to determine its compliance status.

Can Muslims buy shares of Alkermes Plc?

Muslim investors may consider investing in Alkermes Plc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Alkermes Plc classified as NOT HALAL?

Musaffa determines the Shariah status of Alkermes Plc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Alkermes Plc updated?

The Shariah compliance status of Alkermes Plc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Alkermes Plc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Alkermes Plc?

You can check the latest Shariah compliance status of Alkermes Plc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ALKS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Alkermes Plc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Alkermes Plc. Stock Analysis ALKS

United States Health Care Mid Cap Report: Q1, 2026

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. The company is headquartered in Dublin, Dublin and currently employs 2,050 full-time employees. The firm has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. The company focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. The company has a manufacturing facility in Wilmington, Ohio.

Key Statistics of Alkermes Plc (ALKS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$47.66$50.72

Today's Open

$50.50

Volume

2.88M

P/E Ratio (TTM)

36.67

52 Week Range

$25.17$55.67

Market Cap

8.83B

Avg. Volume

1.77M

Dividend Yield

Financial Metrics & Statements of Alkermes Plc (ALKS)

Super Investors Invested in Alkermes Plc (ALKS)

FAQ's for Alkermes Plc (ALKS)

As of July 2026, Alkermes Plc ALKS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alkermes Plc using these criteria to determine its compliance status.
Muslim investors may consider investing in Alkermes Plc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Alkermes Plc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Alkermes Plc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Alkermes Plc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.